Literature DB >> 25565748

Segmental neurofibromatosis.

Virat Galhotra1, Soheyl Sheikh2, Sanjeev Jindal3, Anshu Singla1.   

Abstract

Segmental neurofibromatosis is a rare disorder, characterized by neurofibromas or cafι-au-lait macules limited to one region of the body. Its occurrence on the face is extremely rare and only few cases of segmental neurofibromatosis over the face have been described so far. We present a case of segmental neurofibromatosis involving the buccal mucosa, tongue, cheek, ear, and neck on the right side of the face.

Entities:  

Keywords:  Segmental neurofibromatosis; neurofibromas; von Recklinghausen syndrome

Year:  2014        PMID: 25565748      PMCID: PMC4213880          DOI: 10.4103/0975-962X.140847

Source DB:  PubMed          Journal:  Indian J Dent        ISSN: 0975-962X


INTRODUCTION

Neurofibromatosis (NF) is an autosomal dominant disease, discovered in 1882, by the German pathologist Friedrich Daniel von Recklinghausen, characterized by disordered growth of ectodermal tissues, and is part of a group of disorders called Phakomatoses (neurocutaneous syndrome).[1] Neurofibromatosis type-I (NF-1), also known as von Recklinghausen syndrome, is caused by the mutation of a gene on the long arm of chromosome 17, which encodes a protein known as neurofibromin. The mutant gene is transmitted with an autosomal dominant pattern of inheritance. The incidence of NF-1 is about 1 in 3500 live births.[12] It is characterized by spots of increased skin pigmentation (café au lait spots), combined with peripheral nerve tumors and a variety of other dysplastic abnormalities of the skin, nervous system, bones, endocrine organs, and blood vessels. The localized form of neurofibromatosis type-I, first described by Gammel in 1931, is very rare.[3] Crowe et al. proposed the term sectorial neurofibromatosis for this localized form of neurofibromatosis, and Miller and Sparkes modified the nomenclature to segmental neurofibromatosis (SN) – the current term for neurofibromas of segmental distribution.[4] The commonly affected sites for SN are the thorax and abdomen (55%), upper extremities (20%), and lower limb and face (10% each). Only few cases (less than 10) of segmental neurofibromatosis over the face have been described so far.[5]

CASE REPORT

A 26-year-old female patient reported to the Dental Department complaining about the unesthetic appearance of her face, since eight years [Figure 1]. History revealed that eight years back, the patient underwent surgery in the neck region for a cyst and one to two days after surgery the patient got a swelling on the face. The swelling was of the same size since then and there was no pain associated with the swelling. There was no history of difficulty in breathing or eating.
Figure 1

The unesthetic appearance of the face

The unesthetic appearance of the face On examination, the face of the patient appeared asymmetrical, bilaterally, with a growth on the right side of the face. The skin over the right side of her face was thickened and hyperpigmented, with a soft and loose hanging overgrowth. There were numerous small and large, sessile and pedunculated nodular growths localized on the right side of her neck, with dark-colored underlying skin. The skin over the right cheek and chin area showed coffee-colored pigmentation (café-au-lait spots) [Figure 2].
Figure 2

Nodular growths localized on the right side of the neck with dark colored underlying skin

Nodular growths localized on the right side of the neck with dark colored underlying skin There was a soft, compressible, nontender growth on the lower lip. The right ear showed disfigurement and hypertrophy, with thickened cartilage and overlying hyperpigmented skin [Figure 3].
Figure 3

Disfigurement of the ear and hypertrophy with thickened cartilage and overlying hyperpigmented skin

Disfigurement of the ear and hypertrophy with thickened cartilage and overlying hyperpigmented skin Intraorally there were numerous soft tissue growths with a sessile base seen on the right buccal mucosa [Figure 4] and tongue [Figure 5]. The growths were soft, compressible, and nontender.
Figure 4

Soft tissue growths with sessile bases on right buccal mucosa

Figure 5

Soft tissue growths with sessile bases on the tongue

Soft tissue growths with sessile bases on right buccal mucosa Soft tissue growths with sessile bases on the tongue Laboratory findings revealed a raised erythrocyte sedimentation rate (ESR) (70 mm in the first hour), a decreased hemoglobin level (7.5 gm%), and the enzyme-linked immunosorbent assay (ELISA) was found to be nonreactive. A panoramic radiograph disclosed asymmetric enlargement of the right side of the mandible, with loss of cortication of the lower border in the midline area, expansion of the body of the mandible causing displacement of the teeth, seen on right side, expansion of the right inferior alveolar nerve canal, enlarged mental foramen, resorption of the roots of the mandibular right teeth, and loss of the right antegonial notch. A deficiency was seen on the right side of the maxilla, with crowding of the posterior teeth [Figure 6].
Figure 6

A panoramic radiograph

A panoramic radiograph The right lateral oblique radiograph revealed a deep sigmoid notch, loss of the antegonial notch, an enlarged and rounded coronoid process, with resorption of the mandibular right teeth [Figure 7].
Figure 7

A right lateral oblique radiograph

A right lateral oblique radiograph Subsequently, biopsy of one of the nodules was taken and sent for histopathological examination. The histopathological slide revealed a non-encapsulated tumor of the dermis with a normal overlying epidermis. The tumor consisted of loosely spaced spindle cells and wavy collagenous strands in a clear matrix [Figure 8].
Figure 8

A non-encapsulated tumor of the dermis, with a normal overlying epidermis

A non-encapsulated tumor of the dermis, with a normal overlying epidermis

DISCUSSION

Neurofibromas are the most common benign tumors of NF-1. These tumors are composed of Schwann cells, fibroblasts, mast cells, and vascular components. They can develop at any point along a nerve. There are three subtypes of neurofibromas: Cutaneous, subcutaneous, and plexiform.[12] Neurofibromatosis is often diagnosed because of unusual pigmentary patterns. The café au lait spots are irregularly-shaped, evenly pigmented, brown macules. Most individuals with neurofibromatosis have six or more spots that are 1.5 cm or greater in diameter. In young children, five or more café au lait macules, greater than 0.5 cm in diameter, are suggestive of neurofibromatosis. Less than 1% of the healthy children have three or more such spots, although one or two café au lait macules are commonly encountered in healthy individuals without disease.[125] Bone involvement includes pseudoarthrosis of the tibia, bowing of the long bones, and orbital defects. Localized bony hypertrophy, especially on the face, may be identified. Treatment of neurofibromatosis is predominantly surgical. When neurofibromas increase in size or cause pain, malignant transformation must be suspected, and excision or biopsy must be performed. Acoustic neuromas and tumors that cause tinnitus and vertigo must be excised with great caution. Plastic surgeons may be included in the correction of deformities, especially those of the face. Considering the autosomal dominant inheritance pattern of neurofibromatosis, genetic counseling must be included in the treatment of all patients affected with this disease.[156]
  4 in total

Review 1.  Genetic counseling in segmental neurofibromatosis.

Authors:  J B Sloan; D F Fretzin; D A Bovenmyer
Journal:  J Am Acad Dermatol       Date:  1990-03       Impact factor: 11.527

2.  Segmental neurofibromatosis.

Authors:  R R Roth; R Martines; W D James
Journal:  Arch Dermatol       Date:  1987-07

3.  Segmental neurofibromatosis is caused by somatic mutation of the neurofibromatosis type 1 (NF1) gene.

Authors:  S Tinschert; I Naumann; E Stegmann; A Buske; D Kaufmann; G Thiel; D E Jenne
Journal:  Eur J Hum Genet       Date:  2000-06       Impact factor: 4.246

4.  Segmental neurofibromatosis.

Authors:  R M Miller; R S Sparkes
Journal:  Arch Dermatol       Date:  1977-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.